Latest News: Proscia profiled in KLAS Emerging Company Spotlight.DOWNLOAD THE REPORT

How is artificial intelligence rising to the challenge in breast cancer diagnosis?

By Author Proscia | August 3, 2023

Chief Strategy Officer Nathan Buchbinder is featured in this article alongside our partner Ibex. He comments on the growing impact of AI on breast cancer diagnosis and also explores why an enterprise pathology platform designed to incorporate a wide variety of applications is critical to realizing AI’s full potential.

Our website uses cookies. By using this site, you agree to its use of cookies.